The successful application of NGS technologies to a problem of this scale and scope speaks to the power of innovation. Here are a few new NGS solutions for COVID-19 research applications.

An advanced benchtop imaging solution for both nucleic acid and protein gels, in a compact and evolved package.

By automating tasks and increasing precision, new liquid handling technologies serve to streamline workflows and free up the hands of researchers to focus on the important stuff – the science.

Understanding the strengths and limitations of real-time RT-PCR is essential for examining the current virus outbreak and for those that may emerge in the future.

Intensive analysis of the spike protein led to the development of the first vaccine candidate approved for clinical trials. Perhaps overshadowed, is the unprecedented collaboration between academic scientists, government institutions, and private industry central to this remarkable work.

Harnessing the power of next generation sequencing technologies, in combined approaches, can improve the speed, accuracy, and quality of diagnostic results.